Article Text

Download PDFPDF
Case report
Breast cancer in a patient with Birt-Hogg-Dubé syndrome (BHDS) with dramatic response to neoadjuvant chemotherapy
  1. Vivek Yadala1,
  2. Hassaan Jafri2,
  3. Mary T Legenza3 and
  4. Maria Tirona2
  1. 1 Internal Medicine, Joan C Edwards School of Medicine at Marshall University, Huntington, West Virginia, USA
  2. 2 Hematology/Oncology, Joan C Edwards School of Medicine at Marshall University, Huntington, West Virginia, USA
  3. 3 Breast Surgery, Joan C Edwards School of Medicine at Marshall University, Huntington, West Virginia, USA
  1. Correspondence to Dr Vivek Yadala; yadalavivek.dr{at}gmail.com

Abstract

This is a case of 49-year-old white woman who presented with a rapidly growing right sided breast mass. A subsequent punch biopsy confirmed grade 3 invasive mammary carcinoma of no special type which was negative for oestrogen receptor, progesterone receptor and Her-2 neu overexpression. She was a carrier of folliculin gene mutation that is characteristic of Birt-Hogg-Dubé syndrome (BHDS), a condition known to cause skin lesions, renal cancers and pneumothoraces. Family history revealed patient’s mother, grandmother and maternal aunt developed renal cell carcinomas during their lifetime and were positive for the same germ line mutation. Tumour tissue was positive for TP53 mutation and negative for BRCA1, BRCA2 and other genes commonly associated with breast cancer. We report a patient with BHDS presenting with breast cancer that showed dramatic response to neoadjuvant chemotherapy prior to bilateral mastectomy, local chest wall radiation and 6 months of adjuvant capecitabine.

  • cancer - see oncology
  • cancer intervention
  • breast cancer
  • carcinogenesis
  • radiotherapy
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors VY and HJ contributed towards gathering data, obtaining patient consent and writing the case report. MT and MTL were involved in planning, overseeing the project and subsequently reviewing and editing the case report.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.